#BEGIN_DRUGCARD DB02438

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H14O6

# Chemical_IUPAC_Name:
(3R,4S,5R)-1,4,5,6-tetrahydroxy-3-methoxyhexan-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3-O-Methylfructose in Linear Form

# HET_ID:
3MF

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H14O6/c1-13-7(5(11)3-9)6(12)4(10)2-8/h4,6-10,12H,2-3H2,1H3/t4-,6+,7+/m1/s1

# InChI_Key:
InChIKey=OFSVCCCZZQKHKQ-PIYBLCFFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2438

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
194.1825

# Molecular_Weight_Mono:
194.07903818

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XYC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.9

# Predicted_LogS:
0.42

# Predicted_Water_Solubility:
5.07e+02 g/l

# Primary_Accession_No:
DB02438

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936383

# PubChem_Substance_ID:
46507817

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00180

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CO[C@H]([C@@H](O)[C@H](O)CO)C(=O)CO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:08 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
xylA

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
2510821	Farber GK, Glasfeld A, Tiraby G, Ringe D, Petsko GA: Crystallographic studies of the mechanism of xylose isomerase. Biochemistry. 1989 Sep 5;28(18):7289-97.
3508293	Farber GK, Petsko GA, Ringe D: The 3.0 A crystal structure of xylose isomerase from Streptomyces olivochromogenes. Protein Eng. 1987 Dec;1(6):459-66.
8180169	Lavie A, Allen KN, Petsko GA, Ringe D: X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. Biochemistry. 1994 May 10;33(18):5469-80.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2431

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
42924

# Drug_Target_1_Name:
Xylose isomerase

# Drug_Target_1_Number_of_Residues:
387

# Drug_Target_1_PDB_ID:
2GYI

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01261	AP_endonuc_2

# Drug_Target_1_Protein_Sequence:
>Xylose isomerase
MSYQPTPEDRFTFGLWTVGWQGRDPFGDATRPALDPVETVQRLAELGAHGVTFHDDDLIP
FGSSDTERESHIKRFRQALDATGMTVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTI
RNIDLAVELGAKTYVAWGGREGAESGAAKDVRVALDRMKEAFDLLGEYVTSQGYDTRFAI
EPKPNEPRGDILLPTVGHALAFIERLERPELYGVNPEVGHEQMAGLNFPHGIAQALWAGK
LFHIDLNGQSGIKYDQDLRFGAGDLRAAFWLVDLLESAGYEGPRHFDFKPPRTEDIDGVW
ASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELAQPTAADGVQELLADRTAFEDF
DVDAAAARGMAFERLDQLAMDHLLGAR

# Drug_Target_1_Reaction:
D-xylose = D-xylulose

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Involved in D-xylose catabolism

# Drug_Target_1_SwissProt_ID:
P15587

# Drug_Target_1_SwissProt_Name:
XYLA_STROL

# Drug_Target_1_Synonyms:
EC 5.3.1.5

# Drug_Target_1_Theoretical_pI:
4.76

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02438
